Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $165M (100.0% shares, 0.0% debt)

Holdings (25)

— BIOSPECIFICS TECHNOLOGIES 12.6%

Value $20.7M Shares 461,315 Est. Cost $45.13 Unrealized —

— CTI BIOPHARMA CORP 12.3%

Value $20.17M Shares 4,049,298 Est. Cost $3.59 Unrealized —

— APOLLO ENDOSURGERY INC 10.9%

Value $17.99M Shares 2,577,996 Est. Cost $4.75 Unrealized —

— AMARIN CORP PLC -ADR 10.6%

Value $17.52M Shares 5,670,205 Est. Cost $3.01 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 6.9%

Value $11.43M Shares 600,000 Est. Cost $14.90 Unrealized +12.2%

— VIVEVE MEDICAL INC 6.4%

Value $10.47M Shares 3,849,711 Est. Cost $6.92 Unrealized —

CPIX CUMBERLAND PHARMACEUTICALS 4.5%

Value $7.376M Shares 1,203,339 Est. Cost $5.83 Unrealized +7.4%

— CORREVIO PHARMA CORP 4.4%

Value $7.295M Shares 1,930,022 Est. Cost $3.78 Unrealized —

— ALIMERA SCIENCES INC 4.2%

Value $6.83M Shares 6,981,184 Est. Cost $1.18 Unrealized —

— NOVELION THERAPEUTICS INC 4.0%

Value $6.598M Shares 1,792,911 Est. Cost $8.14 Unrealized —

— HTG MOLECULAR DIAGNOSTICS 3.3%

Value $5.506M Shares 1,689,064 Est. Cost $3.26 Unrealized —

— OPHTHOTECH CORP 3.2%

Value $5.22M Shares 1,912,018 Est. Cost $4.11 Unrealized —

— BIODELIVERY SCIENCES INTL 2.7%

Value $4.384M Shares 1,486,002 Est. Cost $2.06 Unrealized —

— RIGEL PHARMACEUTICALS INC 2.6%

Value $4.235M Shares 1,496,590 Est. Cost $2.83 Unrealized —

ADMA ADMA BIOLOGICS INC 2.3%

Value $3.751M Shares 831,731 Est. Cost $4.98 Unrealized 0.0%

ACAD ACADIA PHARMACEUTICALS INC 1.8%

Value $2.976M Shares 194,900 Est. Cost $17.83 Unrealized 0.0%

ATEC ALPHATEC HOLDINGS INC 1.6%

Value $2.692M Shares 903,224 Est. Cost $3.55 Unrealized 0.0%

— CATABASIS PHARMACEUTICALS IN 1.4%

Value $2.302M Shares 2,400,000 Est. Cost $0.96 Unrealized —

— CIDARA THERAPEUTICS INC 1.3%

Value $2.213M Shares 425,531 Est. Cost $5.20 Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 0.8%

Value $1.393M Shares 198,373 Est. Cost $9.81 Unrealized 0.0%

— CANCER GENETICS INC 0.8%

Value $1.239M Shares 1,391,607 Est. Cost $1.85 Unrealized —

— GEMPHIRE THERAPEUTICS INC 0.6%

Value $1.05M Shares 103,000 Est. Cost $6.51 Unrealized —

— CONFORMIS INC 0.5%

Value $770K Shares 616,109 Est. Cost $1.45 Unrealized —

— MELINTA THERAPEUTICS INC 0.2%

Value $331K Shares 52,200 Est. Cost $6.34 Unrealized —

— INVIVO THERAPEUTICS HOLDINGS 0.1%

Value $132K Shares 77,900 Est. Cost $1.69 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	BIOSPECIFICS TECHNOLOGIES	461,315	$20.7M	12.6%	$45.13	—	COM	090931106
—	CTI BIOPHARMA CORP	4,049,298	$20.17M	12.3%	$3.59	—	COM	12648L601
—	APOLLO ENDOSURGERY INC	2,577,996	$17.99M	10.9%	$4.75	—	COM	03767D108
—	AMARIN CORP PLC -ADR	5,670,205	$17.52M	10.6%	$3.01	—	SPONS ADR NEW	023111206
VNDA	VANDA PHARMACEUTICALS INC	600,000	$11.43M	6.9%	$14.90	+12.2%	COM	921659108
—	VIVEVE MEDICAL INC	3,849,711	$10.47M	6.4%	$6.92	—	COM NEW	92852W204
CPIX	CUMBERLAND PHARMACEUTICALS	1,203,339	$7.376M	4.5%	$5.83	+7.4%	COM	230770109
—	CORREVIO PHARMA CORP	1,930,022	$7.295M	4.4%	$3.78	—	COM	22026V105
—	ALIMERA SCIENCES INC	6,981,184	$6.83M	4.2%	$1.18	—	COM	016259103
—	NOVELION THERAPEUTICS INC	1,792,911	$6.598M	4.0%	$8.14	—	COM NEW	67001K202
—	HTG MOLECULAR DIAGNOSTICS	1,689,064	$5.506M	3.3%	$3.26	—	COM	40434H104
—	OPHTHOTECH CORP	1,912,018	$5.22M	3.2%	$4.11	—	COM	683745103
—	BIODELIVERY SCIENCES INTL	1,486,002	$4.384M	2.7%	$2.06	—	COM	09060J106
—	RIGEL PHARMACEUTICALS INC	1,496,590	$4.235M	2.6%	$2.83	—	COM NEW	766559603
ADMA	ADMA BIOLOGICS INC	831,731	$3.751M	2.3%	$4.98	0.0%	COM	000899104
ACAD	ACADIA PHARMACEUTICALS INC	194,900	$2.976M	1.8%	$17.83	0.0%	COM	004225108
ATEC	ALPHATEC HOLDINGS INC	903,224	$2.692M	1.6%	$3.55	0.0%	COM NEW	02081G201
—	CATABASIS PHARMACEUTICALS IN	2,400,000	$2.302M	1.4%	$0.96	—	COM	14875P107
—	CIDARA THERAPEUTICS INC	425,531	$2.213M	1.3%	$5.20	—	COM	171757107
SNDX	SYNDAX PHARMACEUTICALS INC	198,373	$1.393M	0.8%	$9.81	0.0%	COM	87164F105
—	CANCER GENETICS INC	1,391,607	$1.239M	0.8%	$1.85	—	COM	13739U104
—	GEMPHIRE THERAPEUTICS INC	103,000	$1.05M	0.6%	$6.51	—	COM	36870A108
—	CONFORMIS INC	616,109	$770K	0.5%	$1.45	—	COM	20717E101
—	MELINTA THERAPEUTICS INC	52,200	$331K	0.2%	$6.34	—	COM	58549G100
—	INVIVO THERAPEUTICS HOLDINGS	77,900	$132K	0.1%	$1.69	—	COM PAR	46186M407